Provectus Biopharmaceuticals Inc.

10/28/2021 | Press release | Distributed by Public on 10/28/2021 05:02

Provectus Biopharmaceuticals Announces Presentation of Updated Data from Combination Therapy Trial of PV-10&tm; and Keytruda&tm; for Treatment of Checkpoint-Refractory Advanced[...]